Valeant Pharmaceuticals International Inc. Chief Executive Officer Michael Pearson is taking a medical leave of absence, putting management of the embattled drugmaker in the hands of a team of executives.
In a statement Monday, the company gave no update on the condition of Pearson, who was hospitalized last week with a severe case of pneumonia. The shares sank 8.7 percent to $104.14 at 10:16 a.m. in New York.
06:01 As Schultz Steps Down, Next Starbucks CEO Brings Tech Savvy11
20:56 Trump Transition: Jon Huntsman, John Bolton, Exxon CEO Among State Department Possibilities23
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle14
16:17 Why analysts think Kevin Johnson is the right replacement for Starbucks CEO Howard Schultz10